Skip to content
Screener

Abbott ABT Nutritional Products — Goodwill, non-deductible

Other segment segments

Medical Devices
$17.3B0.0%
Diagnostic Products
$15B+317%
Established Pharmaceuticals
$2.7B0.0%

Similar metrics at other companies

Cadre Holdings logo
CDREProducts — Goodwill
$231.29M+34.6%
TGE
TGENProducts — Goodwill
$0-100%
Ormat Technologies logo
ORAProduct — Goodwill
$0
Nucor logo
NUESteel Products — Goodwill
$2.82B+0.3%
GTL
GTLSSpecialty Products — Goodwill
$583.5M+2.1%
Hasbro logo
HASConsumer Products — Goodwill
$560.9M-64.5%

Other financials

Income statement

See full
Revenue$12.6B+13.0%
Gross profit$7.3B+15.6%
Operating income$1.7B-17.5%
Net income$928.0M-47.8%
EPS (diluted)$0.53-47.5%

Balance sheet

See full
Cash & equivalents$5.1B-26.6%
Total debt$32.6B+143%
Total equity$51.1B+1.1%
Total assets$109.22B+30.0%

Cash flow

See full
Operating cash flow$2.5B+21.5%
CapEx$497.0M-1.0%
Free cash flow$2.0B+28.9%

Valuation

See full
Market cap$182.92B-19.7%
Enterprise value$210.42B-10.2%
P/E33.7×+17.4×
P/S3.9×-1.4×

Profitability

See full
Gross margin56.6%+0.6pp
Operating margin15.8%-1.7pp
Net margin11.6%-20.8pp
FCF margin16.8%+1.1pp

Returns & leverage

See full
Return on equity10.7%-20.4pp
Debt / equity0.6×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The source filing: Abbott’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050134

The total amount of goodwill reported was $35.2 billion at June 30, 2026, and $24.0 billion at December 31, 2025. Goodwill increased by $11.4 billion in the first six months of 2026 due to the completion of the Exact Sciences acquisition. Foreign currency translation adjustments decreased goodwill by $0.2 billion in the first six months of 2026. The amount of goodwill related to reportable segments at June 30, 2026, was $2.7 billion for the Established Pharmaceutical Products segment, $0.3 billion for the Nutritional Products segment, $15.0 billion for the Diagnostic Products segment, and $17.3 billion for the Medical Devices segment. The Diagnostic Products segment includes the amount of goodwill related to the Exact Sciences acquisition. There were no reductions of goodwill relating to impairments in the first six months of 2026.

Item 1. Financial Statements and Supplementary Data

FAQ

What is Abbott's nutritional products — goodwill, non-deductible?
Abbott (ABT) reported nutritional products — goodwill, non-deductible of $300M in Q2 2026.
How has Abbott's nutritional products — goodwill, non-deductible changed year-over-year?
Abbott's nutritional products — goodwill, non-deductible increased by 5.3% year-over-year, from $285M to $300M.
What is the long-term trend for Abbott's nutritional products — goodwill, non-deductible?
Over 4 years (2021 to 2025), Abbott's nutritional products — goodwill, non-deductible has grown at a -0.1% compound annual growth rate (CAGR), from $1.14B to $1.14B.
What does nutritional products — goodwill, non-deductible mean?
The portion of goodwill associated with the nutritional products segment that is not tax-deductible for income tax purposes. This arises from historical acquisitions where the purchase price exceeded the fair value of net identifiable assets, reflecting the premium paid for market position and brand equity.

Ask your AI about Abbott's nutritional products — goodwill, non-deductible.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude